Figure 7.
Linc00963 promotes tumor growth of castration-resistant prostate cancer (CRPC) cells. (A) Tumor growth curve of PC-3 cells infected with Lv-control, Lv-Linc00963-WT and Lv-Linc00963-MUT; (B) Tumor weight of PC-3 cells infected with Lv-control, Lv-Linc00963-WT and Lv-Linc00963-MUT; (C) Relative expression of miR-655 and TRIM24 in resected tumor tissues of Lv-control, Lv-Linc00963-WT and Lv-Linc00963-MUT group; (D) Ki-67-positive cells in nude mice bearing PC-3 cells infected with Lv-control, Lv-Linc00963-WT and Lv-Linc00963-MUT; (E) Statistical analysis of the percentage of Ki-67 positive cells in nude mice bearing PC-3 cells infected with Lv-control, Lv-Linc00963-WT and Lv-Linc00963-MUT; Data are shown as the mean ± S.E. *P < 0.05, ns, not significant. Representative results of 3 independent experiments are shown.